MRI as a central component of clinical trials analysis in brainstem glioma: A report from the Pediatric Brain Tumor Consortium (PBTC)

Neuro-Oncology

Volumn 13, Issue 4, 2011, Pages 417-427

  Poussaint, Tina Young ^a   Kocak, Mehmet ^b   Vajapeyam, Sridhar ^a   Packer, Roger I ^c   Robertson, Richard L ^a   Geyer, Russell ^d   Haas Kogan, Daphne ^e   Pollack, Ian F ^f   Vezina, Gilbert ^c   Zimmerman, Robert ^g   Cha, Soonmee ^e   Patay, Zoltan ^b   Boyett, James M ^b   Kun, Larry E ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Brain tumor; Brainstem glioma; MRI; Pediatric; Radiation

Indexed keywords

GEFITINIB; TIPIFARNIB;

ADOLESCENT; ADULT; ARTICLE; BRAIN STEM GLIOMA; CANCER RADIOTHERAPY; CHILD; DRUG EFFECT; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRESCHOOL CHILD; PROGRESSION FREE SURVIVAL; SCHOOL CHILD; TUMOR GROWTH; TUMOR VOLUME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN STEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DIFFUSION; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; QUINAZOLINES; QUINOLONES; RADIOTHERAPY DOSAGE; RESEARCH DESIGN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79955776393     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/noq200     Document Type: Article

References (33)

1. Jennings MT, Freeman ML, Murray MJ. Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy. J Neurooncol. 1996;28:207-222 (Pubitemid 26192396)
2. Central Brain Tumor Registry of the United States. Statistical Report: Primary Brain Tumors in the United States, 2000-2004. Central Brain Tumor Registry of the United States, Hinsdale, IL 2008
3. Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neurosurgery. 1993;33:1026-1029; discussion 1029-1030.
4. Packer RJ, Boyett JM, Zimmerman RA, et al. Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase l/ll Trial. Cancer. 1993;72:1414-1421 (Pubitemid 23225017)
5. PoussaintTY, Phillips PC, Vajapeyam S, et al. The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress. AJNR Am J Neuroradiol. 2007;28:603-607. (Pubitemid 46608590)
6. Sorensen AG, Patel S, Harmath C, et al. Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol. 2001;19:551-557. (Pubitemid 32112870)
7. Ostergaard L, Sorensen AG, Chesler DA, et al. Combined diffusion-weighted and perfusion-weighted flow heterogeneity magnetic resonance imaging in acute stroke. Stroke. 2000;31:1097-1103 (Pubitemid 30253531)
8. Fischbein N, Prados M, Wara W, Russo C, Edwards M, Barkovich A. Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg. 1996;24:9-23. (Pubitemid 26198320)
9. Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children critical review of clinical trials. Lancet Oncol. 2006;7:241-248. (Pubitemid 43286454)
10. Packer RJ, Littman PA, Sposto RM, et al. Results of a pilot study of hyperfractionated radiation therapy for children with brain stem gliomas. Int J Radiat Oncol Biol Phys. 1987;13:1647-1651 (Pubitemid 17160127)
11. Chenevert TL, Ross BD. Diffusion imaging for therapy response assessment of brain tumor. Neuroimaging Clin N Am. 2009;19:559-571
12. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol. 2007;25:4104-4109. (Pubitemid 47495868)
13. Chen HJ, Panigrahy A, Dhali G, et al. Apparent diffusion and fractional anisotropy of diffuse intrinsic brain stem gliomas. AJNR Am J Neuroradiol. 2010;31:1879-1885.
14. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11:102-125.
15. Kaplan AM, Albright AL, Zimmerman RA, et al. Brainstem gliomas in children: a Children's Cancer Group review of 119 cases. Pediatr Neurosurg. 1996;24:185-192. (Pubitemid 26258955)
16. Packer RJ, Zimmerman RA, Kaplan A, et al. Early cystic/necrotic changes after hyperfractionated radiation therapy in children with brain stem gliomas: data from the Childrens Cancer Group. Cancer. 1993;71:2666-2674. (Pubitemid 23100507)
17. Smith RR, Zimmerman RA, Packer RJ, et al. Pediatric brainstem glioma: postradiation clinical and MR follow-up. Neuroradiology. 1990;32:265-271 (Pubitemid 20264488)
18. Tofilon PJ, Fike JR. The radioresponse of the central nervous system: a dynamic process. Radiat Res. 2000;153:357-370. (Pubitemid 30185388)
19. Coderre JA, Morris GM, Micca PL, et al. Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival. Radiat Res. 2006;166:495-503. (Pubitemid 44353433)
20. Chenevert TL, Meyer CR, Moffat BA, et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging. 2002;1:336-343.
21. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst. 2000;92:2029-2036. (Pubitemid 32045900)
22. Hamstra DA, Galban CJ, Meyer CR, et al. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol. 2008;26:3387-3394.
23. Asao C, Korogi Y, Kitajima M, et al. Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence AJNR Am J Neuroradiol. 2005;26:1455-1460. (Pubitemid 43733446)
24. Ueoka Dl, Nogueira J, Campos JC, Maranhao-Filho P, Ferman S, Lima MA. Brainstem gliomas-retrospective analysis of 86 patients. J Neurol Sci. 2009;281:20-23.
25. Hargrave D, Chuang N, Bouffet E. Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol. 2008;86:313-319.
26. Cha S. Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients. Neuroimaging Clin N Am. 2006;16:137-147, ix.
27. Chang YW, Yoon HK, Shin HJ, Roh HG, Cho JM. MR imaging of glioblastoma in children: usefulness of diffusion/perfusion-weighted MRI and MR spectroscopy. Pediatr Radiol. 2003;33:836-842 (Pubitemid 38008331)
28. Tzika AA, Astrakas LG, Zarifi MK, et al. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Cancer. 2004;100:1246-1256. (Pubitemid 38325953)
29. Turner CD, Chi S, Marcus KJ, et al. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. J Neurooncol. 2007;82:95-101
30. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology. 1994;191:41-51
31. Law M, Oh S, Babb JS, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imagingprediction of patient clinical response. Radiology. 2006;238: 658-667. (Pubitemid 43134379)
32. Leach PA, Estlin EJ, Coope DJ, et al. Diffuse brainstem gliomas in children: should we or shouldn't we biopsy? Br J Neurosurg. 2008;22:619-624.
33. Roujeau T, Machado G, Garnett MR, et al. Stereotactic biopsy of diffuse pontine lesions in children. J Neurosurg. 2007;107(1 Suppl):1-4